We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+6%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.57B
AUM Growth
-$156M
Cap. Flow
-$108M
Cap. Flow %
-4.2%
Top 10 Hldgs %
15.55%
Holding
1,822
New
682
Increased
195
Reduced
247
Closed
625

Top Buys

Rank Stock Value
1
CP icon
Canadian Pacific Kansas City
CP
+$49.4M
2
DHR icon
Danaher
DHR
+$45.2M
3
WFC icon
Wells Fargo
WFC
+$44.1M
4
GLOB icon
Globant
GLOB
+$40.5M
5
EPAM icon
EPAM Systems
EPAM
+$38.7M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 18.73%
3 Healthcare 11.64%
4 Industrials 8.6%
5 Consumer Discretionary 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VELOU
1176
DELISTED
Velocity Acquisition Corp. Units
VELOU
$66K ﹤0.01%
+6,700
New +$67.2K
CNTG
1177
DELISTED
Centogene N.V. Common Shares
CNTG
$63K ﹤0.01%
12,303
-26,357
-68% -$215K
YQ
1178
17 Education & Technology Group
YQ
$20.8M
$54K ﹤0.01%
+8,660
New +$111K
BIOR
1179
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$53K ﹤0.01%
+102
New +$73.2K
VNRX icon
1180
VolitionRx Ltd
VNRX
$10.6M
$50K ﹤0.01%
795
-5,910
-88% -$403K
VELO
1181
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
$49K ﹤0.01%
+5,000
New +$49K
KLDO
1182
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$47K ﹤0.01%
+19,600
New +$79.8K
FUSN
1183
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$46K ﹤0.01%
+11,000
New +$68.6K
BATRK icon
1184
Atlanta Braves Holdings Series B
BATRK
$3.25B
$42K ﹤0.01%
+1,482
New +$42K
UBP
1185
DELISTED
Urstadt Biddle Properties Inc.
UBP
$40K ﹤0.01%
+2,100
New +$37.8K
DHC
1186
Diversified Healthcare Trust
DHC
$2.28B
$38K ﹤0.01%
12,391
-3,564
-22% -$11.5K
UONEK icon
1187
Urban One Class D
UONEK
$22.4M
$36K ﹤0.01%
+1,070
New +$52.4K
LUB
1188
DELISTED
Luby's Inc.
LUB
$33K ﹤0.01%
+11,700
New +$41.6K
ORTX
1189
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$31K ﹤0.01%
+2,317
New +$38.3K
EFA icon
1190
iShares MSCI EAFE ETF
EFA
$76.8B
$28K ﹤0.01%
+351
New +$27.8K
MNOV icon
1191
MediciNova
MNOV
$65M
$28K ﹤0.01%
10,460
-84,035
-89% -$281K
MSAC
1192
CALL
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$15K ﹤0.01%
1,508
DRRX
1193
DELISTED
DURECT Corp
DRRX
$14K ﹤0.01%
1,395
-2,445
-64% -$27K
CALA
1194
DELISTED
Calithera Biosciences, Inc
CALA
$13K ﹤0.01%
965
-12,775
-93% -$321K
TWAV
1195
TaoWeave Inc
TWAV
$4.32M
$11K ﹤0.01%
+19
New +$17.9K
NSTB.U
1196
DELISTED
Northern Star Investment Corp. II Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
NSTB.U
$4K ﹤0.01%
+400
New +$4.01K
AAPL icon
1197
Apple
AAPL
$4.95T
-2,972
Closed -$421K
ABCB icon
1198
Ameris Bancorp
ABCB
$5.77B
-41,096
Closed -$2.13M
ABCL icon
1199
AbCellera Biologics
ABCL
$1.6B
-331,414
Closed -$6.64M
ABEO icon
1200
Abeona Therapeutics
ABEO
$349M
-2,919
Closed -$82K

Similar funds

Ergoteles's Q4 2021 Portfolio in Review

As of Q4 2021, Ergoteles held 1,822 positions worth $2.57B, down 5.7% from $2.73B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ergoteles withdrew a net $108M in Q4 2021, closing 625 positions and reducing 247 holdings. Its most notable exit was Match Group, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ergoteles opened a new position in Canadian Pacific Kansas City worth $48.6M.

  • Ergoteles's largest Q4 2021 buy was Canadian Pacific Kansas City: 676,212 shares worth $48.6M.
  • Ergoteles added most to Applovin in Q4 2021, an estimated $30.5M increase.
  • Ergoteles's biggest Q4 2021 reduction was Oracle, cutting an estimated $50.3M.
  • Ergoteles fully exited Match Group in Q4 2021, selling an estimated $48.3M.
  • Ergoteles's ten largest holdings make up 16% of its $2.57B portfolio in Q4 2021.
  • Ergoteles opened 682 new positions and closed 625 in Q4 2021.
  • Ergoteles's portfolio value fell 5.7% quarter-over-quarter to $2.57B.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.